Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ)
002880.SZ Stock Price Chart
Explore Shenzhen Weiguang Biological Products Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002880.SZ price movements and trends.
002880.SZ Company Profile
Discover essential business fundamentals and corporate details for Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
16 Jun 2017
Employees
859.00
Website
https://www.szwg.comCEO
Caiping Guo
Description
Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous immunoglobulin (pH4), freeze-dried intravenous human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies patient immunoglobulin, tetanus human immunoglobulin, histamine human immunoglobulin, and human fibrinogen, as well as a total of 9 varieties and 21 specifications. Shenzhen Weiguang Biological Products Co., Ltd. was founded in 1985 and is based in Shenzhen, China.
002880.SZ Financial Timeline
Browse a chronological timeline of Shenzhen Weiguang Biological Products Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 22 Apr 2025
EPS came in at ¥0.31, while revenue for the quarter reached ¥349.09M.
Earnings released on 31 Mar 2025
EPS came in at ¥0.19, while revenue for the quarter reached ¥225.00M.
Earnings released on 25 Oct 2024
EPS came in at ¥0.32, while revenue for the quarter reached ¥331.20M.
Earnings released on 27 Aug 2024
EPS came in at ¥0.28, while revenue for the quarter reached ¥294.13M.
Dividend declared on 12 Jul 2024
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 12 Jul 2024.
Earnings released on 26 Apr 2024
EPS came in at ¥0.21, while revenue for the quarter reached ¥226.30M.
Earnings released on 22 Feb 2024
EPS came in at ¥0.30, while revenue for the quarter reached ¥313.07M.
Dividend declared on 31 Oct 2023
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 31 Oct 2023.
Earnings released on 25 Oct 2023
EPS came in at ¥0.22, while revenue for the quarter reached ¥278.27M.
Earnings released on 24 Aug 2023
EPS came in at ¥0.24, while revenue for the quarter reached ¥248.65M.
Earnings released on 26 Apr 2023
EPS came in at ¥0.20, while revenue for the quarter reached ¥256.50M.
Earnings released on 31 Mar 2023
EPS came in at ¥0.20, while revenue for the quarter reached ¥208.52M.
Earnings released on 30 Oct 2022
EPS came in at ¥0.11, while revenue for the quarter reached ¥179.59M.
Earnings released on 29 Aug 2022
EPS came in at ¥0.10, while revenue for the quarter reached ¥94.06M.
Dividend declared on 8 Jul 2022
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 8 Jul 2022.
Earnings released on 29 Apr 2022
EPS came in at ¥0.11, while revenue for the quarter reached ¥137.78M, missing expectations by -89.25%.
Earnings released on 15 Apr 2022
EPS came in at ¥0.11, while revenue for the quarter reached ¥290.68M.
Earnings released on 26 Oct 2021
EPS came in at ¥0.30, while revenue for the quarter reached ¥280.97M.
Earnings released on 19 Aug 2021
EPS came in at ¥0.19, while revenue for the quarter reached ¥197.14M.
Dividend declared on 16 Jun 2021
A dividend of ¥0.18 per share was announced, adjusted to ¥0.18. The dividend was paid on 16 Jun 2021.
Stock split effective on 16 Jun 2021
Shares were split 7:5, changing the number of shares outstanding and the price per share accordingly.
Earnings released on 28 Apr 2021
EPS came in at ¥0.17, while revenue for the quarter reached ¥138.65M.
Earnings released on 13 Apr 2021
EPS came in at ¥0.31, while revenue for the quarter reached ¥296.90M.
Earnings released on 27 Oct 2020
EPS came in at ¥0.19, while revenue for the quarter reached ¥200.10M.
Earnings released on 21 Aug 2020
EPS came in at ¥0.20, while revenue for the quarter reached ¥218.09M.
002880.SZ Stock Performance
Access detailed 002880.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.